Corbus Pharmaceuticals (CRBP) Stock Chart & Stock Price History → America’s worst nightmare? (From Porter & Company) (Ad) Free CRBP Stock Alerts $42.99 +0.12 (+0.28%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corbus Pharmaceuticals Stock Price Performance5 Day Performance-1.71%1 Month Performance+5.24%3 Month Performance+91.07%6 Month Performance+1,010.85%Year-To-Date Performance+611.75%1 Year Performance+336.89% Receive CRBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsDid Intel Just Dethrone Nvidia?Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet. You can get all the details here. CRBP Stock Chart for Wednesday, May, 15, 2024 CRBP Chart by TradingView Corbus Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$42.87$42.99+0.28%$43.64$42.39106,440 shs$459.43 million05/13/2024$42.99$42.87-0.28%$44.80$41.67151,962 shs$458.28 million05/10/2024$43.74$42.99-1.71%$43.88$40.5192,122 shs$451.70 million05/09/2024$42.39$43.74+3.18%$43.81$42.34650,384 shs$459.58 million05/08/2024$39.77$42.39+6.59%$44.66$39.31779,160 shs$445.52 million05/07/2024$38.82$39.77+2.45%$40.34$37.91160,188 shs$417.98 million Get the Latest News and Ratings for CRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$38.77$38.82+0.13%$39.24$37.52108,035 shs$408.00 million05/03/2024$38.20$38.77+1.49%$39.23$37.41134,675 shs$407.47 million05/02/2024$37.25$38.20+2.55%$39.37$37.62140,840 shs$401.48 million05/01/2024$37.04$37.25+0.57%$38.58$36.60133,291 shs$391.50 million04/30/2024$35.64$37.04+3.93%$37.04$34.93197,470 shs$389.29 million04/29/2024$34.25$35.64+4.06%$36.24$34.4992,781 shs$374.47 million04/26/2024$33.50$34.25+2.24%$34.63$32.2796,874 shs$359.97 million04/25/2024$35.54$33.50-5.74%$35.09$32.03142,333 shs$352.09 million04/24/2024$37.74$35.54-5.83%$38.34$34.24220,992 shs$373.53 million04/23/2024$37.70$37.74+0.11%$40.08$37.66500,504 shs$396.65 million04/22/2024$39.24$37.70-3.92%$39.94$36.8294,727 shs$396.23 million04/19/2024$36.53$39.24+7.42%$39.86$35.79283,601 shs$412.41 million04/18/2024$37.16$36.53-1.70%$37.78$35.26128,015 shs$383.93 million04/17/2024$41.12$37.16-9.63%$41.12$36.09419,840 shs$390.55 million04/16/2024$42.72$41.12-3.75%$45.00$40.96353,253 shs$432.17 million04/15/2024$40.85$42.72+4.58%$42.96$39.58347,486 shs$448.86 million04/12/2024$40.00$40.85+2.13%$40.99$39.17291,720 shs$429.33 million04/11/2024$38.15$40.00+4.85%$40.15$37.00186,773 shs$420.28 million04/10/2024$37.47$38.15+1.81%$38.56$35.5065,900 shs$400.96 million04/09/2024$40.16$37.47-6.70%$40.89$36.01232,344 shs$393.81 million04/08/2024$39.97$40.16+0.48%$42.20$37.50208,997 shs$422.08 million04/05/2024$38.97$39.97+2.57%$40.35$38.81151,833 shs$420.09 million04/04/2024$38.50$38.97+1.22%$40.67$38.77161,340 shs$409.58 million04/03/2024$37.46$38.50+2.78%$40.29$37.01274,207 shs$404.64 million04/02/2024$37.99$37.46-1.40%$40.64$35.80270,881 shs$393.71 million04/01/2024$39.24$37.99-3.19%$40.94$37.99173,177 shs$399.28 million03/29/2024$39.24$39.24$40.00$35.16235,133 shs$412.41 million03/28/2024$35.57$39.24+10.32%$39.96$35.16234,957 shs$412.41 million03/27/2024$36.15$35.57-1.60%$36.53$33.24179,249 shs$373.84 million03/26/2024$35.63$36.15+1.46%$38.24$35.34239,802 shs$379.21 million03/25/2024$34.94$35.63+1.97%$36.56$35.00296,512 shs$373.76 million03/22/2024$38.15$34.94-8.41%$38.00$34.44187,536 shs$366.52 million03/21/2024$39.17$38.15-2.60%$39.46$37.26293,968 shs$400.19 million03/20/2024$42.76$39.17-8.40%$43.76$38.65275,150 shs$410.89 millionWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 202403/19/2024$41.62$42.76+2.74%$43.86$39.50134,554 shs$448.55 million03/18/2024$43.68$41.62-4.72%$43.13$39.01328,120 shs$436.59 million03/15/2024$45.13$43.68-3.21%$46.74$42.28633,281 shs$458.20 million03/14/2024$47.08$45.13-4.14%$48.07$43.98296,127 shs$437.31 million03/13/2024$44.58$47.08+5.61%$49.87$45.15478,462 shs$456.21 million03/12/2024$38.28$44.58+16.46%$45.33$39.82595,987 shs$431.98 million03/11/2024$44.93$38.28-14.80%$43.49$37.01409,968 shs$370.93 million03/08/2024$40.32$44.93+11.43%$46.19$38.15770,991 shs$435.37 million03/07/2024$33.58$40.32+20.07%$42.60$35.86888,026 shs$390.70 million03/06/2024$34.60$33.58-2.95%$38.99$33.58192,353 shs$325.39 million03/05/2024$36.32$34.60-4.74%$38.06$32.17438,729 shs$335.27 million03/04/2024$35.00$36.32+3.77%$37.80$33.50370,220 shs$351.94 million03/01/2024$30.90$35.00+13.27%$35.00$30.36335,774 shs$339.15 million02/29/2024$28.00$30.90+10.36%$31.51$26.82647,496 shs$299.42 million02/28/2024$26.07$28.00+7.40%$28.50$25.21140,518 shs$271.32 million02/27/2024$28.52$26.07-8.59%$28.65$26.07243,688 shs$252.62 million02/26/2024$25.75$28.52+10.76%$29.00$25.01179,795 shs$249.47 million02/23/2024$25.45$25.75+1.18%$26.25$24.93208,146 shs$249.52 million02/22/2024$27.15$25.45-6.26%$27.69$24.11192,619 shs$246.56 million02/21/2024$23.30$27.15+16.52%$28.56$23.68816,335 shs$263.08 million02/20/2024$23.10$23.30+0.87%$23.95$23.20117,990 shs$225.78 million02/19/2024$23.10$23.10$24.14$21.97259,400 shs$223.84 million02/16/2024$22.48$23.10+2.76%$24.14$21.97259,306 shs$223.84 million02/15/2024$22.50$22.48-0.09%$23.20$22.0083,877 shs$217.83 million02/14/2024$22.00$22.50+2.27%$24.35$21.76129,808 shs$218.03 million02/13/2024$23.00$22.00-4.35%$23.22$21.31107,670 shs$213.18 million Related Companies: MRSN Stock Price Chart ANNX Stock Price Chart BMEA Stock Price Chart HRTX Stock Price Chart ANRO Stock Price Chart KRRO Stock Price Chart AMRN Stock Price Chart LXRX Stock Price Chart ADCT Stock Price Chart NGNE Stock Price Chart Receive CRBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRBP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.